Latest filing published 07 Jan 2025 for 东星医疗, €1,143.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +18.9%Entry CN¥22.32 · Close at T+365 CN¥26.53
- +45.8%Entry CN¥19.14 · Close at T+365 CN¥27.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
龚爱琴: trading record in brief
龚爱琴, listed as senior executive, appears in our data through filings on 东星医疗 shares, published by SSE / SZSE (CSRC). In total, 2 filings cover trades dated from 26 August 2024 to 7 January 2025.
Purchases make up the whole of the open-market record (2 purchases, €18k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2025, the count stands at 1 purchase and no sales.
The record was last updated on 7 January 2025 with an open-market purchase (€1,143) in 东星医疗. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 龚爱琴
Open company profiles for insider transactions, fundamentals and analyst consensus when available.